Sobre
With nearly two decades in clinical research, I'm at the forefront of revolutionizing…
Artigos de Moe
-
Clinical Trail Vanguard Newsletter August 1,2024
Clinical Trail Vanguard Newsletter August 1,2024
De Moe Alsumidaie
-
Clinical Trial Vanguard Newsletter July 9, 2024
Clinical Trial Vanguard Newsletter July 9, 2024
De Moe Alsumidaie
Contribuições
Atividades
-
📈 ✨ 👩 💊 Adopting AI is a moral obligation to humanize drug development. Insightful perspectives shared at the FDA Public workshop on the Use of…
📈 ✨ 👩 💊 Adopting AI is a moral obligation to humanize drug development. Insightful perspectives shared at the FDA Public workshop on the Use of…
Moe Alsumidaie gostou
-
Take a moment to share feedback to a survey and help an industry peer in their academic journey (this is for doctoral research, not for the benefit…
Take a moment to share feedback to a survey and help an industry peer in their academic journey (this is for doctoral research, not for the benefit…
Moe Alsumidaie gostou
-
COYA 301 and Glucagon-Like Peptide-1 receptor agonists (GLP-1 RAs) are showing promise in the fight against inflammatory diseases. Their synergistic…
COYA 301 and Glucagon-Like Peptide-1 receptor agonists (GLP-1 RAs) are showing promise in the fight against inflammatory diseases. Their synergistic…
Compartilhado por Moe Alsumidaie
Experiência
Formação acadêmica
-
Northeastern University - Graduate School of Business Administration
Atividades e grupos:Member, Beta Gamma Sigma
Magna Cum Laude
-
-
Licenças e certificados
-
Clinical Trials Design & Management
University of California, San Diego
Publicações
-
RbM Guidance Document: Ten Burning Questions about Risk-Based Study Management
Applied Clinical Trials Online
The RbM Consortium is a transnational alliance of quality risk management industry experts, risk-based technology firms, data analysts, and biopharmaceutical business strategists. Members of this group include WSQMS, PPH plus, Cyntegrity, and Annex Clinical. The objective of this collaboration is to improve awareness of Risk-based Monitoring (RbM) in clinical trials, to advise biopharmaceutical enterprises, medical device companies, CROs, study sponsors, and study sites on best practices, and…
The RbM Consortium is a transnational alliance of quality risk management industry experts, risk-based technology firms, data analysts, and biopharmaceutical business strategists. Members of this group include WSQMS, PPH plus, Cyntegrity, and Annex Clinical. The objective of this collaboration is to improve awareness of Risk-based Monitoring (RbM) in clinical trials, to advise biopharmaceutical enterprises, medical device companies, CROs, study sponsors, and study sites on best practices, and communicating the best implementation strategies on sound quality risk management systems, technologies, and business methodologies in RbM. This guidance document offers information about RbM strategies.
Outros autoresVer publicação -
Improving Clinical Trial Quality & Productivity at Investigative Sites
Applied Clinical Trials
This article outlines some of the challenges associated with realizing clinical trial productivity at investigative sites and offers a few suggestions for strategic positioning.
-
Clinical Research in the New Economy
Applied Clinical Trials
This article describes the future of clinical trials, and what biopharmaceutical and medical device enterprises need to do in order to position their staff for operating more successfully.
-
Risk-based monitoring could simplify trial data QC, according to Annex Clinical
Outsourcing-Pharma.com
Risk-based monitoring means certain aspects of clinical trials can be quality checked using a segment of the data, according to Annex Clinical.
-
Risk Based Monitoring on Regulatory Document Reconciliation
Moe Alsumidaie
This case study shows how a team was able to perform risk-based monitoring techniques to enhance compliance, improve efficiency and save costs in clinical operations.
-
Niche clinical trial areas could be way for CROs and IT providers to crack cloud market
Financial Times
This article speaks about how clinical trial IT solutions may be acquired by CROs
Outros autoresVer publicação
Cursos
-
Abnormal Clinical Psychology
PSYC163
-
Animal Behavior & Communication
BIEB166
-
Animal Physiology Laboratory
BIPN105
-
Biological Oceanography
BIEB134
-
Biometry
BIEB100
-
Brand and Advertising Management
MKTG6223
-
Business Turnarounds
FINA6205
-
Calculus & Analytics, Geometry, Science & Engineering
MATH20C
-
Comparative Physiology
BIPN106
-
Creating & Sustain Customer Markets
MKTG200
-
Digital Marketing
MKTG6222
-
Electricity, Magnetism & Thermodynamics
PHYS1B
-
Ethics in Workplace
MGMT6213
-
Finance Seminar
FINA6206
-
Financial Decision Making
FING200
-
Financial Management Accounting
ACCG218
-
Financial Strategy
FINA6205
-
Genetics
BICD100
-
Global Competition & Market Dominance
MECG200
-
Information Analysis
MSCG200
-
International Financial Management
FINA6204
-
Investment Analysis
FINA6203
-
Investment Portfolio Management
FINA6219
-
Mammalian Physiology I
BIPN100
-
Mammalian Physiology II
BIPN102
-
Managing Information Resources
MSCG204
-
Managing the Global Enterprise
INBG200
-
Market Research
MKTG6210
-
Metabolic Biochemistry
BIBC102
-
Molecular Biology
BIMM100
-
Nutrition
BIBC120
-
Organizations in the New Economy
HRMG6200
-
Psychology, Teaching & Structural Information
TEP116
-
Real Estate Finance & Investment
FINA6217
-
Service & Manufacturing Operations Management
MGSC6206
-
Strategic Decision-Making
MGMT6200
-
Systems Neurobiology
BIPN142
-
Technology & Entrepreneurship
ENTR6200
-
Waves, Optics & Modern Physics
PHYS1C
Reconhecimentos e prêmios
-
Beta Gamma Sigma Member
Beta Gamma Sigma
Admitted to Beta Gamma Sigma for Academic Achievement at NEU.
Idiomas
-
English
Nível nativo ou bilíngue
-
French
Nível nativo ou bilíngue
-
Arabic
Nível nativo ou bilíngue
-
Portuguese
Nível básico a intermediário
Organizações
-
Association of Clinical Research Professionals (ACRP)
-
- o momento
Recomendações recebidas
17 pessoas recomendaram Moe
Cadastre-se agora para visualizarMais atividade de Moe
-
SanBio Co. Ltd has achieved a groundbreaking milestone in Japan with the approval of "AKUUGO® Suspension for Intracranial Implantation," a cell-based…
SanBio Co. Ltd has achieved a groundbreaking milestone in Japan with the approval of "AKUUGO® Suspension for Intracranial Implantation," a cell-based…
Compartilhado por Moe Alsumidaie
-
The FDA has approved Jemperli (dostarlimab-gxly) in combination with chemotherapy (carboplatin and paclitaxel), followed by Jemperli alone, for…
The FDA has approved Jemperli (dostarlimab-gxly) in combination with chemotherapy (carboplatin and paclitaxel), followed by Jemperli alone, for…
Compartilhado por Moe Alsumidaie
-
BostonGene and Takeda are collaborating on research studies in immuno-oncology. Their partnership focuses on enhancing clinical trial design…
BostonGene and Takeda are collaborating on research studies in immuno-oncology. Their partnership focuses on enhancing clinical trial design…
Compartilhado por Moe Alsumidaie
-
Vivacelle Bio, Inc. and CEO Harven DeShield, PhD, JD, MSc are featured in The Clinical Trial Vanguard. Thanks to Moe…
Vivacelle Bio, Inc. and CEO Harven DeShield, PhD, JD, MSc are featured in The Clinical Trial Vanguard. Thanks to Moe…
Moe Alsumidaie gostou